NASDAQ:MNDR - KYG622641176 - Common Stock
The current stock price of MNDR is 0.96 USD. In the past month the price increased by 4.12%. In the past year, price decreased by -84.49%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 11.54 | 92.78B | ||
CI | THE CIGNA GROUP | 10.71 | 80.31B | ||
LH | LABCORP HOLDINGS INC | 18.36 | 23.10B | ||
DGX | QUEST DIAGNOSTICS INC | 19.2 | 20.31B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.6 | 15.08B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.31 | 14.46B | ||
DVA | DAVITA INC | 14.22 | 9.85B | ||
HIMS | HIMS & HERS HEALTH INC | 52.94 | 9.57B | ||
GH | GUARDANT HEALTH INC | N/A | 8.41B | ||
CHE | CHEMED CORP | 20.47 | 6.67B | ||
RDNT | RADNET INC | 199.33 | 5.52B | ||
OPCH | OPTION CARE HEALTH INC | 21.24 | 4.65B |
Mobile-health Network Solutions is an investment holding company, which engages in the provision of telehealth solutions through MaNaDr platform. The firm provides its services on its MaNaDr platform, which is a 360-degree healthcare ecosystem which connects users and service providers through a range of healthcare services and product offerings that can be accessed through its mobile application and Website. Through its mobile application, it offers users seamless and hassle-free telehealth solutions, which encompass teleconsultation services, including the issuance of electronic medical certificates and delivery of medications to users’ homes and other personalized services. Its segments are telemedicine and other services and the sale of medicine and medical devices. The platform encompasses various components: MaNaDr Mobile Application; MaNaDr Clinic; MaNaPharma; MaNaShop/MaNaStore and MaNaCare. The company offers a diversified range of products to users on the MaNaShop/MaNaStore online e-commerce platform, including healthcare products.
MOBILE-HEALTH NETWORK SOLUTI
Cricket Square, Hutchins Drive, P.O. Box 2681
George Town KY
Employees: 73
Phone: 3456562225223
The current stock price of MNDR is 0.96 USD. The price decreased by -4.95% in the last trading session.
The exchange symbol of MOBILE-HEALTH NETWORK SOLUTI is MNDR and it is listed on the Nasdaq exchange.
MNDR stock is listed on the Nasdaq exchange.
7 analysts have analysed MNDR and the average price target is 65.28 USD. This implies a price increase of 6700% is expected in the next year compared to the current price of 0.96. Check the MOBILE-HEALTH NETWORK SOLUTI stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MOBILE-HEALTH NETWORK SOLUTI (MNDR) has a market capitalization of 4.20M USD. This makes MNDR a Nano Cap stock.
MOBILE-HEALTH NETWORK SOLUTI (MNDR) currently has 73 employees.
MOBILE-HEALTH NETWORK SOLUTI (MNDR) has a resistance level at 1.1. Check the full technical report for a detailed analysis of MNDR support and resistance levels.
The Revenue of MOBILE-HEALTH NETWORK SOLUTI (MNDR) is expected to grow by 81.13% in the next year. Check the estimates tab for more information on the MNDR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MNDR does not pay a dividend.
MOBILE-HEALTH NETWORK SOLUTI (MNDR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.87).
The outstanding short interest for MOBILE-HEALTH NETWORK SOLUTI (MNDR) is 1.34% of its float. Check the ownership tab for more information on the MNDR short interest.
ChartMill assigns a technical rating of 1 / 10 to MNDR. When comparing the yearly performance of all stocks, MNDR is a bad performer in the overall market: 97.96% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to MNDR. The financial health of MNDR is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months MNDR reported a non-GAAP Earnings per Share(EPS) of -4.87. The EPS decreased by -342.98% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -401.37% | ||
ROE | -678.46% | ||
Debt/Equity | 0 |
7 analysts have analysed MNDR and the average price target is 65.28 USD. This implies a price increase of 6700% is expected in the next year compared to the current price of 0.96.
For the next year, analysts expect an EPS growth of 96.15% and a revenue growth 81.13% for MNDR